Animal models paved the way for Phase III testing of the COVID-19 vaccine

Yesterday, NIH and Moderna announced the start of a multi-site, Phase 3 clinical trial of a candidate vaccine for COVID-19. This candidate vaccine uses messenger RNA, or mRNA, a “codebook” that cellular machinery “reads” in order to build proteins. For this candidate vaccine, the mRNA contains instructions for building spike proteins found on the coronavirus, … Continue reading Animal models paved the way for Phase III testing of the COVID-19 vaccine